Estimating Metastatic Risk of Pancreatic Ductal Adenocarcinoma at Single-Cell Resolution

Pancreatic ductal adenocarcinoma (PDAC) is characterized by intra-tumoral heterogeneity, and patients are always diagnosed after metastasis. Thus, finding out how to effectively estimate metastatic risk underlying PDAC is necessary. In this study, we proposed scMetR to evaluate the metastatic risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Sina, Zhou, Shunheng, Huang, Yu-e, Yuan, Mengqin, Lei, Wanyue, Chen, Jiahao, Lin, Kongxuan, Jiang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736800/
https://www.ncbi.nlm.nih.gov/pubmed/36499343
http://dx.doi.org/10.3390/ijms232315020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736800/
https://www.ncbi.nlm.nih.gov/pubmed/36499343
http://dx.doi.org/10.3390/ijms232315020

Ejemplares similares